Literature DB >> 6678200

Chloroquine in long-term treatment of rheumatoid arthritis.

A Bjelle, A Björnham, A Larsen, T Mjörndal.   

Abstract

The effect of long-term (18-70 months) chloroquine treatment 250 mg daily, in rheumatoid arthritis (RA) was studied in 20 patients. Sedimentation rates were significantly reduced, as compared to a reference group of 10 RA patients on no treatment of disease modifying anti-rheumatic drugs. Radiographical progression of the disease was low in the majority of chloroquine-treated patients but not significantly different from the finding in the patients of the reference group. Rapid radiographical progression during 2-3 years was, however, observed in 5 patients despite chloroquine treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6678200     DOI: 10.1007/bf02041561

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

1.  Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis.

Authors:  E B HAMILTON; J T SCOTT
Journal:  Arthritis Rheum       Date:  1962-10

2.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

3.  A controlled study of chloroquine as an antirheumatic agent.

Authors:  A S COHEN; E CALKINS
Journal:  Arthritis Rheum       Date:  1958-08

4.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

5.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

Review 6.  Antimalarials in the management of discoid and systemic lupus erythematosus.

Authors:  E L Dubois
Journal:  Semin Arthritis Rheum       Date:  1978-08       Impact factor: 5.532

7.  A 15 month controlled study of the effects of amodiaquine (camoquin) in rheumatoid arthritis.

Authors:  C R BEPLER; H N BAIER; S McCRACKEN; C L RENTSCHLER; F B ROGERS; J LANSBURY
Journal:  Arthritis Rheum       Date:  1959-10

8.  Chloroquine treatment in rheumatoid arthritis. Correlation of clinical response to plasma protein changes and chloroquine levels.

Authors:  F A Wollheim; A Hanson; C B Laurell
Journal:  Scand J Rheumatol       Date:  1978       Impact factor: 3.641

9.  Antimalarials in rheumatic diseases.

Authors:  R O Day; P Sambrook; G D Champion; G G Graham
Journal:  Aust N Z J Med       Date:  1982-12

10.  Is chloroquine obsolete in treatment of rheumatic disease?

Authors:  J S Marks; B J Power
Journal:  Lancet       Date:  1979-02-17       Impact factor: 79.321

View more
  3 in total

1.  How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?

Authors:  J S Dixon; M Greenwood; H A Bird
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

Review 2.  Wide field retinal imaging and the detection of drug associated retinal toxicity.

Authors:  Giulia Corradetti; Sara Violanti; Adrian Au; David Sarraf
Journal:  Int J Retina Vitreous       Date:  2019-12-12

Review 3.  Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.

Authors:  Zi-Ning Lei; Zhuo-Xun Wu; Shaowei Dong; Dong-Hua Yang; Litu Zhang; Zunfu Ke; Chang Zou; Zhe-Sheng Chen
Journal:  Pharmacol Ther       Date:  2020-09-08       Impact factor: 12.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.